Could John McCain kill the Republican health-care bill again?


Sen. John McCain (R-Ariz.) stunned his colleagues in the Senate when he torpedoed the Republican health-care bill with a tie-breaking no vote in July. With the GOP prepared to send its latest iteration of the health-care bill to the floor sometime next week, McCain is now poised to potentially make or break the legislation yet again.
Republicans have a Sept. 30 deadline for passing a health-care bill with only 50 votes. The Congressional Budget Office won't have its analysis on how much the bill would affect coverage or its costs for consumers until October. Additionally, the hearing on the bill will be before the Senate Homeland Security and Government Affairs committee, which "does not have primary jurisdiction over health care, making a formal markup of the bill impossible," Politico writes.
Despite the bill's co-sponsor, Sen. Lindsey Graham (R-S.C.), being McCain's close friend, McCain has stressed to Politico that he is dissatisfied with how his party is pushing the bill. "Nothing has changed," he said Wednesday. "If [Senate Majority Leader Mitch] McConnell wants to put it on the floor, that's up to McConnell. I am the same as I was before. I want the regular order."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Asked to clarify if that means he is voting no, McCain replied: "That means I want the regular order. It means I want the regular order!"
Three GOP defections would kill the bill. Sens. Susan Collins (R-Maine) and Rand Paul (R-Ky.) are believed to be opposed to the bill. In addition to McCain, Sen. Lisa Murkowski (R-Alaska) is reportedly on the fence about the legislation.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Israel: Losing the American public
Feature A recent poll finds American support for Israel's military action in Gaza has fallen from 50% to 32%
-
Unmaking Americans
Feature Trump is threatening to revoke the citizenship of foreign-born Americans. Could he do that?
-
EPA: A bonfire of climate change regulations
Feature The Environmental Protection Agency wants to roll back its 'endangerment finding,' a ruling that lets the agency regulate carbon emissions
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts